Forensic 10-K and 10-Q Podcast

Forensic 10-K and 10-Q Podcast

0.0 (0)
Investing
Updated Daily

Get the podcast delivered every quarter directly. Subscribe on https://10kfm.com for latest podcast on any 10K /10Q filings . Podcast includes AI Generated content. Searchable terms: 10K, 10Q, SEC filings, Annual reports, quarterly reports, Financial Deep Dive.

7h ago

Backside Power Delivery Transition | $AMAT Q3 2026 10-Q

EXECUTIVE SUMMARY Applied Materials (($1)) recently filed its Form 10-Q for the third quarter of fiscal 2026, revealing a complex operational transition. While headline numbers suggest steady demand driven by artificial intelligence infrastructure, a closer look at the operational footprint reveals an aggressive shift toward advanced packaging and backside power delivery systems. This strategic pivot is designed to offset slowing growth in traditional node scaling. However, escalating export controls and regional concentration risks present structural vulnerabilities that management is scrambling to mitigate through supply chain diversification. DEEP DIVE: OPERATIONAL SHIFTS & ASSET FOOTPRINT The real story within this filing lies in the reallocation of research and development resources. Applied Materials is aggressively shifting its capital expenditure toward advanced packaging technologies, specifically targeting gate-all-around (GAA) transistor architectures and backside power delivery networks. As physical limitations prevent traditional lithography from delivering historical performance gains, the industry is forced to rely on system-level scaling. AMAT is positioning itself as the primary tollkeeper for this new era, deploying substantial capital to expand its advanced packaging development facilities in Singapore and the United States. This operational shift is not merely a technological choice; it is a survival strategy. By embedding its proprietary tools deeper into the advanced packaging workflow, the company secures long-term customer lock-in with major foundries. This integration makes it incredibly difficult for competitors to displace AMAT, even as hardware sales cycles fluctuate. Furthermore, the company's Applied Global Services segment continues to grow, providing a highly predictable, high-margin recurring revenue stream that cushions the cyclical volatility of the semiconductor systems business. However, this transition requires a massive overhaul of the company's global asset footprint. AMAT is currently diversifying its manufacturing operations away from historically concentrated regions in Northeast Asia. The filing details increased investment in manufacturing capacity in Southeast Asia, particularly in Malaysia and Singapore. This geographic dispersion is an expensive endeavor that temporarily weighs on operating efficiency, but it is deemed necessary to establish a more resilient supply chain capable of weathering sudden geopolitical disruptions. THE FOOTNOTE RISKS (THE BEAR CASE) A rigorous examination of the legal and regulatory disclosures in the 10-Q reveals significant headwinds that the market seems to be discounting. The most pressing threat stems from increasingly stringent export control regulations imposed by the United States and other jurisdictions. These regulations restrict the sale of advanced semiconductor manufacturing equipment and services to certain customers in China. Given that China has historically accounted for a substantial portion of AMAT's net sales, any further tightening of these rules could severely impact future revenue streams. The footnotes also reveal ongoing investigations by multiple government agencies, including the U.S. Department of Justice and the SEC, regarding the company's historical shipments to certain Chinese customers. While management asserts compliance with all applicable laws, the legal defense costs are escalating, and the potential for material fines or operational restrictions remains a dark cloud over the stock. Additionally, the company is facing intense competition from domestic equipment manufacturers in restricted regions, who are rapidly developing alternative... Get Latest 10K or 10Q filings for any ticker at https://10kfm.com
18h ago

Is $QUBT a Buy? Commercializing Photonic Chip Production [Q2 2026]

EXECUTIVE SUMMARY Quantum Computing Inc. is attempting a high-stakes operational pivot from software development to hardware manufacturing. ($1) is betting its future on its Tempe, Arizona fabrication facility to produce thin-film lithium niobate photonic chips. However, the underlying financials reveal severe structural vulnerabilities, including a persistent going concern warning and an extremely limited cash runway that threatens long-term viability. DEEP DIVE: OPERATIONAL SHIFTS & ASSET FOOTPRINT Quantum Computing Inc. is undergoing a fundamental structural shift. Historically, the company positioned itself as a software-first player, attempting to sell its Qatalyst software suite to bridge classical and quantum systems. That strategy failed to generate meaningful commercial traction. Now, management has pivoted the entire corporate identity toward hardware manufacturing, specifically focusing on thin-film lithium niobate (TFLN) optical chips. The centerpiece of this strategy is their Tempe, Arizona fabrication facility. Operating a proprietary semiconductor cleanroom is an incredibly capital-intensive endeavor. Unlike fabless chip designers, QUBT is taking on the full operational burden of manufacturing. TFLN is a promising material for electro-optic modulators, offering higher bandwidth and lower power consumption than traditional silicon photonics. However, manufacturing these chips at scale is notoriously difficult. The etching process for lithium niobate is highly sensitive, and achieving commercially viable yields is a major technical hurdle. If the Tempe facility suffers from low yield rates or equipment downtime, the cost per wafer will skyrocket, rendering their hardware uncompetitive against established silicon photonics foundries. Furthermore, the market for quantum-adjacent hardware is highly fragmented. QUBT is not just competing against other quantum startups; they are competing against massive, well-capitalized defense contractors and semiconductor giants who are also developing optical interconnects. The company's ability to secure long-term purchase agreements is entirely unproven. Without committed off-take agreements from major telecom, defense, or high-performance computing clients, the Tempe facility risks becoming an expensive, underutilized asset that drains cash rather than generating it. THE FOOTNOTE RISKS (THE BEAR CASE) The most alarming disclosures are buried deep within the financial footnotes, specifically the going concern warning. QUBT is operating with an accumulated deficit of over $QUBT million. Their current cash balance of $QUBT million provides less than two quarters of runway at their current burn rate of approximately $QUBT million per month. This is a classic liquidity trap. To keep the lights on, management has repeatedly turned to highly dilutive financing mechanisms. The reliance on an equity line of credit (ELOC) means the company is constantly issuing new shares into the market to fund basic operations. This continuous dilution acts as a massive drag on the share price, punishing long-term retail holders. If the stock price falls too low, the efficacy of the ELOC diminishes, creating a death spiral dynamic where they must issue exponentially more shares to raise the same amount of capital. Additionally, the footnotes reveal a precarious lack of customer diversification. A significant portion of their minimal revenue is derived from a handful of short-term government research contracts and pilot programs. These contracts do not provide the recurring, high-margin revenue stream needed to... Get Latest 10K or 10Q filings for any ticker at https://10kfm.com
19h ago

Is $QUIK a Buy? Securing Embedded FPGA Defense Wins [Q2 2026]

EXECUTIVE SUMMARY QuickLogic Corp (($1)) is undergoing a quiet but fundamental transition away from legacy mobile hardware toward high-margin embedded FPGA (eFPGA) intellectual property licensing. The latest 10-Q for the period ending June 28, 2026, reveals a complex operational picture. While top-line growth shows promise due to defense and aerospace design wins, the balance sheet reflects significant working capital friction. This analysis bypasses the surface-level earnings press release to examine the structural shifts in contract assets, customer concentration, and the long-term viability of their IP-centric business model. DEEP DIVE: OPERATIONAL SHIFTS & ASSET FOOTPRINT The core of QuickLogic's thesis rests on its proprietary eFPGA technology, specifically the QuickAI and Australis platforms. Historically, the company struggled with low-margin sensor processing hardware. The current operational shift focuses on licensing software and silicon IP to defense contractors and aerospace giants who require highly customizable, radiation-hardened programmable logic. This strategy is highly capital-light compared to traditional fabless chip design, as it shifts the burden of physical manufacturing and wafer procurement to the licensees. This transition is not merely about software licensing; it represents a fundamental reconfiguration of how QuickLogic interacts with the silicon ecosystem. By utilizing their Australis eFPGA generator, they can deliver custom IP blocks in days rather than months, creating a highly scalable design pipeline. This rapid deployment capability is crucial for defense applications where system specifications change rapidly in response to emerging electronic warfare threats. However, this operational pivot alters the company's asset footprint. Physical inventory is declining, replaced by intangible contract assets and unbilled receivables. These contract assets represent revenue recognized under ASC 606 for milestones achieved but not yet billed to the client. The doubling of contract assets to $QUIK million indicates that while engineering teams are hitting development milestones, cash collection is lagging. Furthermore, QuickLogic is actively migrating its physical manufacturing partnerships. By aligning with domestic foundries like SkyWater Technology, the company is positioning itself to capture secure US government defense contracts. This domestic supply chain realignment is a critical hedge against geopolitical instability in the Taiwan Strait, which remains a systemic risk for the broader semiconductor industry. THE FOOTNOTE RISKS (THE BEAR CASE) The primary risk hidden in the footnotes is extreme customer concentration. The top three customers accounted for over 65% of total revenue during the quarter, with a single defense prime contractor representing 38% of the backlog. This concentration introduces immense volatility; if a single program is delayed or canceled by the Department of Defense, QuickLogic's revenue trajectory collapses. Additionally, the cash conversion cycle has deteriorated. Operating cash flow fell deeper into negative territory at negative $QUIK million, driven by the lag between milestone recognition and actual cash receipts. The company is essentially funding its customers' development cycles upfront. With cash and cash equivalents standing at a modest $QUIK million, the runway is tight. Any prolonged delay in milestone payments will force QuickLogic to tap its equity line of credit, diluting existing shareholders. A closer look at the legal disclosures reveals that while there is... Get Latest 10K or 10Q filings for any ticker at https://10kfm.com
1d ago

Is $MU a Buy? Scaling High-Bandwidth Memory Nodes [Q3 2026]

EXECUTIVE SUMMARY Micron Technology Inc's (($1)) latest 10-Q filing reveals a high-stakes operational gamble that the broader market is mispricing. While headline numbers suggest a standard cyclical recovery, the footnotes show a massive, forced reallocation of wafer capacity toward High-Bandwidth Memory (HBM3E). This structural shift is cannibalizing legacy DRAM supply, creating a dual-edged sword of near-term margin pressure and long-term enterprise lock-in. We analyze the operational friction points, CapEx trajectories, and lithography bottlenecks that management is trying to gloss over. DEEP DIVE: OPERATIONAL SHIFTS & ASSET FOOTPRINT The core of Micron's strategy lies in its aggressive transition to the 1-beta and 1-gamma DRAM nodes. This transition is not a simple software patch or minor tooling upgrade. It requires a fundamental reconfiguration of cleanroom space across their fabrication facilities in Hiroshima, Japan, and Taichung, Taiwan. By dedicating more physical cleanroom footprint to the complex packaging steps required for HBM3E, Micron is effectively reducing its total wafer starts for standard DDR5 and LPDDR5X. This wafer cannibalization is a deliberate operational choice. HBM3E requires approximately double the wafer processed area compared to standard DDR5 for the same gigabit output. Consequently, even if Micron's factories run at 100% utilization, their net bit shipment growth for standard DRAM will flatline. This structural supply constraint is designed to force enterprise customers into long-term supply agreements (LTAs) at premium pricing. However, it leaves Micron highly vulnerable to any operational disruptions. If their advanced packaging yields in Taichung drop even by a few percentage points, they will fail to meet both HBM3E commitments and standard DRAM demand, leaving billions in unfulfilled orders on the table. Furthermore, the transition to EUV (Extreme Ultraviolet) lithography for the 1-gamma node represents a massive execution risk. Micron has historically lagged behind competitors in EUV adoption, relying instead on multi-patterning DUV (Deep Ultraviolet) systems. The integration of ASML's EUV systems into the Hiroshima fab is currently underway, but the learning curve is steep. Any calibration delays or downtime in these EUV modules will directly stall the 1-gamma ramp, forcing Micron to rely on older, less cost-efficient nodes while competitors scale. THE FOOTNOTE RISKS (THE BEAR CASE) A close reading of the risk factors and commitments sections reveals several critical vulnerabilities. First, Micron's purchase commitments for wafer fabrication equipment (WFE) have surged to historic highs. This massive capital outlay is highly illiquid and front-loaded. If the current AI-driven demand cycle experiences even a minor pause or digestion phase in late 2026, Micron will be left with underutilized, highly depreciating assets that will crush gross margins. Second, the filing highlights escalating geopolitical and regulatory hurdles. With major manufacturing hubs concentrated in Taiwan and Japan, Micron is highly exposed to regional supply chain disruptions. Specifically, the ongoing export control adjustments on advanced semiconductor equipment could restrict Micron's ability to move critical tooling between its global sites. Additionally, the company is facing ongoing patent litigation regarding its 3D NAND and DRAM stacking technologies. While management downplays these disputes as routine, a negative ruling could restrict sales of... Get Latest 10K or 10Q filings for any ticker at https://10kfm.com
1d ago

Strategic Pivot: $SLS Q2 2026 — Accelerating Phase Three Trials

EXECUTIVE SUMMARY SELLAS Life Sciences Group, Inc. (($1)) is operating on a razor-thin margin of error. The latest 10-Q filing highlights a company entirely dependent on a single clinical outcome: the Phase 3 REGAL trial of galinpepimut-S (GPS) in acute myeloid leukemia. Management has systematically paused early-stage pipeline development to funnel remaining capital into this late-stage asset. While this focus accelerates clinical timelines, it exposes investors to extreme binary risk and imminent dilutive financing. DEEP DIVE: OPERATIONAL SHIFTS & ASSET FOOTPRINT The operational footprint of SELLAS has contracted significantly over the past two quarters. Management is executing a severe prioritization strategy. By halting the development of SLS009 (their CDK9 inhibitor) in secondary solid tumor indications, the company has managed to temporarily reduce its R&D burn rate. This is not an expansion; it is a defensive consolidation. The capital saved is being redirected exclusively to clinical site maintenance and patient monitoring for the REGAL trial. This operational pivot has major implications for long-term enterprise value. If GPS fails to meet its primary endpoints, SELLAS has no viable backup pipeline ready for rapid clinical advancement. The company's physical asset footprint is virtually non-existent, as they rely entirely on third-party contract manufacturing organizations (CMOs) for the production of GPS and SLS009. This outsourcing strategy keeps fixed costs low but introduces massive supply chain vulnerabilities. Any disruption at their partner CMO facilities could delay the Chemistry, Manufacturing, and Controls (CMC) validation process, which is required for any future Biologics License Application (BLA) submission to the FDA. Furthermore, the clinical site footprint is highly decentralized. Managing dozens of active clinical sites globally during a cash crunch introduces significant administrative friction. The filing reveals that accrued clinical trial expenses have risen, indicating that SELLAS is stretching its payment terms with clinical research organizations (CROs). This is a classic sign of working capital strain that could lead to operational bottlenecks if CRO partners demand upfront payments for upcoming data analysis phases. THE FOOTNOTE RISKS (THE BEAR CASE) The footnotes of this 10-Q paint a far more alarming picture than the headline loss reduction. The most critical risk is the explicit "going concern" warning. With only $SLS million in cash and cash equivalents, the company's current runway is measured in months, not years. Management openly admits that existing capital is insufficient to fund operations through the next twelve months without securing additional non-dilutive or dilutive financing. Dilution is not just a risk; it is an active operational mechanism for SELLAS. The company has continuously utilized its At-The-Market (ATM) equity offering program to survive. During the quarter, millions of shares were issued, putting downward pressure on the stock price and diluting existing shareholders. Additionally, outstanding warrants represent a massive overhang on the capital structure. If the stock price spikes on positive clinical news, these warrants will likely be exercised, capping upward momentum. On the regulatory front, the path to approval for GPS is fraught with CMC hurdles. The FDA has tightened its requirements for biologics manufacturing validation. Even if... Get Latest 10K or 10Q filings for any ticker at https://10kfm.com
2d ago

Is $WKHS a Buy? Pivoting to Regional Fleet Sales [Q2 2026]

EXECUTIVE SUMMARY Workhorse Group Inc. (($1)) continues to navigate an incredibly narrow operational runway, as revealed in its latest 10-Q filing for the period ending June 30, 2026. The company is aggressively shifting its commercial strategy away from slow-moving national enterprise accounts toward highly localized, municipal fleet sales that can leverage immediate state-level green incentives. While this tactical pivot reduces immediate customer acquisition costs, the underlying financial reality remains grim. Structural cash burn and persistent production bottlenecks for the W56 platform threaten to cut this transition short unless immediate non-dilutive financing is secured. DEEP DIVE: OPERATIONAL SHIFTS & ASSET FOOTPRINT The most significant operational shift detailed in this filing is the complete reorganization of the sales pipeline. Management has realized that chasing Tier-1 logistics providers is a losing battle in the short term. These massive enterprises require multi-year pilot programs and extensive customization, which a cash-starved entity cannot support. Instead, Workhorse is focusing its manufacturing capacity on the W56 step van and targeting regional municipal fleets, particularly in states like California and New York where voucher incentive programs (such as HVIP) significantly offset the upfront acquisition cost for buyers. This operational pivot is also forcing a consolidation of the company's physical footprint. Workhorse is underutilizing its Union City, Indiana manufacturing facility, operating at a fraction of its total capacity to conserve cash. While this limits immediate overhead, it creates a structural inefficiency: the unit economics of the W56 remain highly unfavorable because the company cannot achieve the purchasing scale necessary to drive down bill-of-materials costs. The transition to a build-to-order model helps prevent inventory obsolescence but severely limits their ability to rapidly fulfill sudden large-scale orders. Furthermore, the drone division (HorseFly) remains in a state of operational limbo. While the technology has received regulatory clearances, commercialization has been deprioritized to preserve capital for the core EV business. This represents a significant write-down risk for capitalized R&D assets if the company cannot find a strategic partner or buyer for its aerospace intellectual property in the coming quarters. THE FOOTNOTE RISKS (THE BEAR CASE) A cynical reading of the footnotes reveals several critical red flags that the market is largely ignoring. First, the going concern warning has been reiterated with heightened urgency. With only $WKHS million in cash and cash equivalents against a quarterly cash burn rate exceeding $WKHS million, Workhorse is entirely dependent on continuous dilutive equity financing or highly restrictive debt agreements to survive the next six months. Second, the reliance on state-level incentive programs is a double-edged sword. Any regulatory delay or budget reallocation in California's HVIP program would instantly freeze the company's sales pipeline. The filing notes that a substantial portion of their current backlog is contingent on these vouchers being approved and funded. If political or fiscal shifts disrupt these state programs, Workhorse will have virtually no viable market for its high-cost electric vans. Finally, there is the persistent threat of supply chain concentration. Workhorse relies on a limited number of tier-one suppliers for critical components, including... Get Latest 10K or 10Q filings for any ticker at https://10kfm.com
2d ago

Is $COHR a Buy? Restructuring Silicon Carbide Assets [FY2026]

EXECUTIVE SUMMARY Coherent Corp. (($1)) recently filed its Form 10-K for the fiscal year ended June 30, 2026, revealing a massive operational pivot. While AI-driven demand for 800G and 1.6T optical transceivers is surging, the company is quietly restructuring its capital-intensive Silicon Carbide (SiC) segment. This transition represents a high-stakes bet on high-margin datacom components at the expense of near-term industrial and automotive growth. Our analysis suggests that while this shift improves near-term cash flow, it exposes the company to severe customer concentration risks and structural supply chain vulnerabilities. DEEP DIVE: OPERATIONAL SHIFTS & ASSET FOOTPRINT The operational playbook at Coherent has undergone a dramatic transformation under CEO Jim Anderson. The legacy strategy, which focused on aggressive capacity expansion across both materials and optoelectronic components, has been replaced by a rigorous cost-control mandate. The primary driver of this shift is the consolidation of manufacturing facilities. Coherent is actively reducing its footprint in high-cost regions and shifting assembly and test operations to optimized hubs in Malaysia and Vietnam. This consolidation is designed to drive higher utilization rates, which historically hovered in the low 60% range for their legacy industrial laser business. The crown jewel of the current portfolio is the datacom segment, specifically the 800G and next-generation 1.6T optical transceivers. These components are critical for AI cluster networking, and demand from hyperscale data centers has been explosive. However, this rapid scaling has created an operational bottleneck. Coherent relies on specialized laser diodes manufactured in its domestic fabs, and any yield issues at these facilities directly impact transceiver output. Furthermore, the transition to 1.6T transceivers requires advanced packaging technologies that are currently operating at near-maximum capacity, limiting near-term upside unless capital expenditure is reallocated. To fund this optical ramp, Coherent is executing a major strategic retreat in its Silicon Carbide (SiC) business. Rather than continuing to fund the massive capital expenditures required to scale 200mm SiC wafer fabrication independently, the company is pursuing an asset-light joint-venture model. This move effectively offloads a significant portion of the capital burden to external partners. While this preserves cash and immediately boosts operating margins, it represents a long-term strategic compromise. By relinquishing full operational control over its SiC wafer supply, Coherent risks losing its competitive edge in the rapidly growing electric vehicle and power electronics markets. THE FOOTNOTE RISKS (THE BEAR CASE) A rigorous examination of the financial footnotes reveals several structural vulnerabilities that the market is currently ignoring. First, inventory write-downs remain a persistent drag. In the legacy industrial and consumer laser segments, Coherent recorded $COHR million in inventory write-downs due to demand destruction in the European industrial sector. This indicates that the legacy business is deteriorating faster than the AI datacom business is growing, masking underlying weakness in the core industrial portfolio. Second, the company's balance sheet remains highly leveraged. Following the massive II-VI acquisition, Coherent carried over $COHR billion in long-term debt. Although management prioritized debt paydown this fiscal year, reducing the principal by $COHR million, interest expense still consumed a staggering $COHR... Get Latest 10K or 10Q filings for any ticker at https://10kfm.com
2d ago

$LITE FY2026 10-K Analysis: Scaling Global Transceiver Production

EXECUTIVE SUMMARY Lumentum Holdings Inc. (($1)) is quietly executing a high-stakes operational migration of its primary manufacturing footprint. As hyperscale data centers demand unprecedented bandwidth to support generative AI clusters, Lumentum's legacy manufacturing footprint faces severe geopolitical and tariff pressures. This 10-K filing reveals an aggressive capital reallocation toward Southeast Asian facilities, specifically scaling cleanroom operations in Thailand. While the market focuses on short-term margin volatility, the real story lies in this massive, friction-filled supply chain pivot that will determine whether Lumentum can defend its market share against low-cost competitors. DEEP DIVE: OPERATIONAL SHIFTS & ASSET FOOTPRINT The core of Lumentum's long-term strategy is the rapid expansion of its Pathum Thani, Thailand manufacturing campus. This isn't just a routine capacity addition; it is a wholesale relocation of advanced optical transceiver assembly and testing. Historically, Lumentum relied heavily on contract manufacturers and internal facilities in regions now subject to escalating trade tensions and tariff risks. By consolidating its next-generation transceiver production—specifically the 800G and emerging 1.6T optical engines—into Thailand, management is attempting to build a tariff-resilient operational moat. However, moving precision optical manufacturing is incredibly complex. These devices require sub-micron alignment and highly specialized cleanroom environments. The 10-K indicates that Lumentum is front-loading capital expenditures to qualify these new lines with major hyperscale customers. This qualification process is a double-edged sword. While it secures long-term customer lock-in once completed, any delay in customer sign-offs or initial yield optimization will result in underabsorbed manufacturing overhead, dragging down gross margins. The operational risk here is concentrated: Lumentum must maintain flawless execution during a period of peak demand, or risk losing first-mover advantage to agile competitors who did not have to undergo a simultaneous geographic migration. The integration of Cloud Light, acquired to bolster Lumentum's active optical cable and transceiver capabilities, adds another layer of operational complexity. Integrating two distinct manufacturing cultures and supply chains while simultaneously relocating facilities is a massive managerial challenge. The 10-K notes that integration costs have continued to weigh on GAAP operating income. If the synergy targets for Cloud Light are delayed, the expected cost savings from the Thailand consolidation will materialize much slower than management's optimistic guidance suggests. THE FOOTNOTE RISKS (THE BEAR CASE) A cynical reading of the risk factors and footnotes reveals several structural vulnerabilities that the bulls are ignoring. First, customer concentration remains a glaring risk. Lumentum's top three customers account for a significant portion of its optical communications revenue. If any of these hyperscalers delay their transition to next-gen architectures or opt for a secondary source due to Lumentum's transition bottlenecks, the impact on the top line will be immediate and severe. Second, the transition costs are heavily impacting cash flow. Operating cash flow declined by nearly 12% year-over-year, driven by working capital build-ups as Lumentum maintains safety stock in multiple locations to prevent supply disruptions during the factory transition. This dual-operating model—running legacy lines while ramping new ones—is an expensive insurance policy. Furthermore, the footnotes disclose ongoing intellectual property litigation and rising compliance... Get Latest 10K or 10Q filings for any ticker at https://10kfm.com

Get the podcast delivered every quarter directly. Subscribe on https://10kfm.com for latest podcast on any 10K /10Q filings . Podcast includes AI Generated content. Searchable terms: 10K, 10Q, SEC filings, Annual reports, quarterly reports, Financial Deep Dive.

Creator

Forensic 10-K and 10-Q Podcast
Years Active

2026
Episodes

25
Show Website

Forensic 10-K and 10-Q Podcast